FI942932A0 - Farmaceutisk komposition och förfarande för dess framställning - Google Patents

Farmaceutisk komposition och förfarande för dess framställning

Info

Publication number
FI942932A0
FI942932A0 FI942932A FI942932A FI942932A0 FI 942932 A0 FI942932 A0 FI 942932A0 FI 942932 A FI942932 A FI 942932A FI 942932 A FI942932 A FI 942932A FI 942932 A0 FI942932 A0 FI 942932A0
Authority
FI
Finland
Prior art keywords
preparation
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
FI942932A
Other languages
English (en)
Finnish (fi)
Other versions
FI942932A (sv
Inventor
Kalman Magyar
Jozsef Gaaol
Istvan Sziraki
Jozsef Lengyel
Szabo Anna Z
Katalin Marmarosi
Istvan Hermecz
Istvan Szatmari
Zoltan Toeroek
Peter Koermoeczy
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of FI942932A0 publication Critical patent/FI942932A0/sv
Publication of FI942932A publication Critical patent/FI942932A/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI942932A 1991-12-20 1994-06-17 Farmaceutisk komposition och förfarande för dess framställning FI942932A (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU914060A HUT63579A (en) 1991-12-20 1991-12-20 Process for producing double-phase pharmaceutical compositions suitable for treating diseases occurring during neurodegenerative processes
PCT/HU1992/000060 WO1993012775A1 (en) 1991-12-20 1992-12-18 Pharmaceutical composition and process for the preparation thereof

Publications (2)

Publication Number Publication Date
FI942932A0 true FI942932A0 (sv) 1994-06-17
FI942932A FI942932A (sv) 1994-06-17

Family

ID=10966728

Family Applications (1)

Application Number Title Priority Date Filing Date
FI942932A FI942932A (sv) 1991-12-20 1994-06-17 Farmaceutisk komposition och förfarande för dess framställning

Country Status (27)

Country Link
US (1) US5589513A (sv)
EP (1) EP0617615A1 (sv)
JP (1) JPH07502730A (sv)
KR (1) KR940703655A (sv)
AU (1) AU677170B2 (sv)
BG (1) BG98827A (sv)
BR (1) BR9206950A (sv)
CA (1) CA2125776A1 (sv)
CZ (1) CZ147494A3 (sv)
EC (1) ECSP930933A (sv)
EE (1) EE03015B1 (sv)
FI (1) FI942932A (sv)
HU (2) HUT63579A (sv)
IL (1) IL104150A (sv)
LT (1) LT3119B (sv)
LV (1) LV10386B (sv)
MY (1) MY111055A (sv)
NO (1) NO942303D0 (sv)
NZ (1) NZ246384A (sv)
PH (1) PH31073A (sv)
PL (1) PL172048B1 (sv)
RO (1) RO115785B1 (sv)
RU (1) RU2125448C1 (sv)
SI (1) SI9200404A (sv)
SK (1) SK74494A3 (sv)
WO (1) WO1993012775A1 (sv)
ZA (1) ZA929883B (sv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5844003A (en) * 1991-04-04 1998-12-01 Innovations Foundation Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
DE4432610C1 (de) * 1994-09-13 1996-02-01 Knoll Ag Verfahren zur Herstellung von Selegilin-Hydrochlorid
AU723047B2 (en) 1995-02-10 2000-08-17 University Of Toronto Innovations Foundation, The Deprenyl compounds for treatment of glaucoma
JP4499208B2 (ja) * 1998-10-29 2010-07-07 株式会社フジモト・コーポレーション 新規な光学活性アミノペンタン誘導体
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
HUP9902482A2 (hu) * 1999-07-22 2002-04-29 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. P-fluoro-selegilin alkalmazása neuroprotektív gyógyszerkészítmények előállítására
EP2053033A1 (en) * 2007-10-26 2009-04-29 Bayer Schering Pharma AG Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
DE102009045056A1 (de) * 2009-09-28 2011-03-31 Henkel Ag & Co. Kgaa Fleckenvorbehandlungsmittel
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
JP2020503269A (ja) 2016-11-28 2020-01-30 リポカイン インコーポレーテッド 経口ウンデカン酸テストステロン療法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1227447B (de) * 1962-03-30 1966-10-27 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung von Phenylisopropylaminen
HU193662B (en) * 1983-12-20 1987-11-30 Chinoin Gyogyszer Es Vegyeszet Process for producing synergetic pharmaceutical composition of antidepressive aktivity
HU207282B (en) * 1984-05-31 1993-03-29 Chinoin Gyogyszer Es Vegyeszet Process for producing phenyl-alkyl-amine derivatives and pharmaceutical compositions containing them
DE3764144D1 (de) * 1986-04-16 1990-09-13 Asta Pharma Ag Synergistische kombination von amantadin und selegilin.
HU207280B (en) * 1986-09-25 1993-03-29 Chinoin Gyogyszer Es Vegyeszet Process for producing new phenyl-alkyl-amines and pharmaceutical compositions containing them
HU197510B (en) * 1986-12-19 1989-04-28 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing phenyl-alkyl-amine derivatives, against motion-sick
US4861800A (en) * 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
GB8807504D0 (en) * 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds
HU208484B (en) * 1988-08-17 1993-11-29 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
CA2037178A1 (en) * 1990-02-28 1991-08-29 Albert Walter Brzeczko Deprenyl/l-dopa/carbidopa pharmaceutical composition
GB9011767D0 (en) * 1990-05-25 1990-07-18 Britannia Pharmaceuticals Ltd Pharmaceutical compositions
US5169868A (en) * 1991-03-01 1992-12-08 University Of Saskatchewan Aliphatic propargylamines as specific mao-b inhibitors
US5444095A (en) * 1991-04-04 1995-08-22 University Of Toronto, Innovations Foundation Use of deprenyl to rescue damaged nerve cells
HU209605B (en) * 1991-04-15 1994-09-28 Chinoin Gyogyszer Es Vegyeszet Process for production of wather-free transdermal preparation
US5326770A (en) * 1992-07-17 1994-07-05 The Du Pont Merck Pharmaceutical Company Monoamine oxidase-B (MAO-B) inhibitory 5-substituted 2,4-thiazolidinediones useful in treating memory disorders of mammals

Also Published As

Publication number Publication date
CZ147494A3 (en) 1995-01-18
LV10386A (lv) 1995-02-20
HU914060D0 (en) 1992-03-30
RO115785B1 (ro) 2000-06-30
HUT63579A (en) 1993-09-28
US5589513A (en) 1996-12-31
ECSP930933A (es) 1994-04-20
ZA929883B (en) 1994-05-16
BR9206950A (pt) 1995-11-28
PH31073A (en) 1998-02-05
CA2125776A1 (en) 1993-07-08
EE03015B1 (et) 1997-08-15
IL104150A (en) 1997-11-20
NZ246384A (en) 1996-02-27
AU3265293A (en) 1993-07-28
RU2125448C1 (ru) 1999-01-27
PL172048B1 (pl) 1997-07-31
JPH07502730A (ja) 1995-03-23
LTIP249A (en) 1994-07-15
HU211478A9 (en) 1995-11-28
SK74494A3 (en) 1995-01-12
LT3119B (en) 1994-12-27
SI9200404A (en) 1993-06-30
WO1993012775A1 (en) 1993-07-08
NO942303D0 (no) 1994-06-17
MY111055A (en) 1999-08-30
FI942932A (sv) 1994-06-17
LV10386B (en) 1995-12-20
KR940703655A (ko) 1994-12-12
BG98827A (en) 1995-06-30
AU677170B2 (en) 1997-04-17
EP0617615A1 (en) 1994-10-05
NO942303L (sv) 1994-08-17

Similar Documents

Publication Publication Date Title
FI941137A (sv) 2-debensoyl-2-acyltaxolderivat och förfaranden för framställning av dessa
FI101310B1 (sv) Polymerkomposition och förfarande för dess framställning
EE03108B1 (et) Farmatseutiline kompositsioon
FI981777A (sv) Farmaceutisk sammansättning
BR1100824A (pt) Composto e composição farmacêutica
FI962445A0 (sv) Paroxetintabletter och förfarande för framställning av dem
FI942913A0 (sv) Isatinderivat, förfarande för deras framställning och farmaceutiska kompositioner innehållande dem
FI942932A0 (sv) Farmaceutisk komposition och förfarande för dess framställning
BR9200058A (pt) Composto e composicao farmaceutica
IT1239542B (it) Composizione farmaceutica comprendente piroxicam e procedimento per lasua preparazione
MX9200622A (es) Composicion farmaceutica
FI940775A0 (sv) Förfarande för framställning av alfa-fenylisoserinderivat och användning av dem
NZ236483A (en) Glycerol derivatives and pharmaceutical compositions thereof
FI955123A (sv) Komposition innehållande kolestyramin och förfarande för framställning av densamma
FI940403A (sv) Ellipticinderivat och förfarande för dess framställning
EE9500029A (et) Farmatseutiline pihustatav kompositsioon ja selle saamise meetod
BR9200004A (pt) Composto,metodo para sua preparacao,e formulacao farmaceutica
FI934387A0 (fi) 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner
EE9400182A (et) Peptiidühendid, nende kasutamine, valmistamismeetod ja farmatseutiline segu
FI941800A0 (sv) Farmaceutiska sammansättningar som är verksamma mot psoriasis samt ett förfarande för framställning därav
EE03101B1 (et) Peptiidühendid, nende kasutamine, valmistamismeetod ja farmatseutiline kompositsioon
IT1224244B (it) Composizione farmaceutica anoressizzante comprendente 5-idrossitrpofano
FI922257A0 (sv) Tvättmedel och förfarande för dess framställning
BR1100486A (pt) Composto e composição farmacêutica
GB9122886D0 (en) Pharmaceutical composition and method